CDKN1B and prostate carcinoma: Caffeic acid phenethyl ester (CAPE) treatment, a natural derivative of CA, induces cell cycle arrest and growth inhibition in desmoplastic resistant prostate cancer (CRPC) cells by regulating Skp2, p53, p21Cip1, and p27Kip1 [30].